document type sequence filename description exhibit text html head title title head body style font time roman time serif style margin text align right style font normal time roman time serif margin text align right text indent nbsp style font normal time roman time serif margin text align right text indent exhibit style font time roman time serif margin confidential treatment requested style font time roman time serif margin certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font time roman time serif margin nbsp style font normal time roman time serif margin text align center text indent master license agreement style font normal time roman time serif margin text align center text indent nbsp style font normal time roman time serif margin text align center text indent between style font normal time roman time serif margin text align center text indent nbsp style font normal time roman time serif margin text align center text indent purdue research foundation style font normal time roman time serif margin text align center text indent nbsp style font normal time roman time serif margin text align center text indent style font normal time roman time serif margin text align center text indent nbsp style font normal time roman time serif margin text align center text indent endocyte style font normal time roman time serif margin text align center text indent nbsp style font normal time roman time serif margin text align center text indent table content style font normal time roman time serif margin text align center text indent nbsp style font time roman time serif margin style font time roman time serif margin table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align background color style width text indent line height font style font time roman time serif section definition font style width text indent line height text align right font style font time roman time serif font style vertical align background color white style text indent line height font style font time roman time serif section grant license font style text indent line height text align right font style font time roman time serif font style vertical align background color style text indent line height font style font time roman time serif section diligence commercialization font style text indent line height text align right font style font time roman time serif font style vertical align background color white style text indent line height font size font style font time roman time serif section consideration license font style text indent line height text align right font style font time roman time serif font style vertical align background color style text indent line height font style font time roman time serif section payment report font style text indent line height text align right font style font time roman time serif font style vertical align background color white style text indent line height font style font time roman time serif section record font style text indent line height text align right font style font time roman time serif font style vertical align background color style text indent line height font style font time roman time serif section patent prosecution font style text indent line height text align right font style font time roman time serif font style vertical align background color white style text indent line height font style font time roman time serif section abatement infringement font style text indent line height text align right font style font time roman time serif font style vertical align background color style text indent line height font style font time roman time serif section confidentiality font style text indent line height text align right font style font time roman time serif font style vertical align background color white style text indent line height font style font time roman time serif section nbsp nbsp dispute resolution font style text indent line height text align right font style font time roman time serif font style vertical align background color style text indent line height font style font time roman time serif section warranty merchantability exclusion warranty font style text indent line height text align right font style font time roman time serif font style vertical align background color white style text indent line height font style font time roman time serif section damage indemnification insurance font style text indent line height text align right font style font time roman time serif font style vertical align background color style text indent line height font style font time roman time serif section term termination font style text indent line height text align right font style font time roman time serif font style vertical align background color white style text indent line height font style font time roman time serif section notice font style text indent line height text align right font style font time roman time serif font style vertical align background color style text indent line height font style font time roman time serif section miscellaneous font style text indent line height text align right font style font time roman time serif font style vertical align background color white style text indent line height font style font time roman time serif exhibit font style text indent line height text align right font style font time roman time serif font style vertical align background color style text indent line height font style font time roman time serif schedule nbsp nbsp elected eligible disclosure licensed patent font style text indent line height text align right font style font time roman time serif font style vertical align background color white style text indent line height font style font time roman time serif schedule commercialization plan font style text indent line height text align right font style font time roman time serif font style vertical align background color style text indent line height font style font time roman time serif schedule royalty report requirement font style text indent line height text align right font style font time roman time serif font table style font time roman time serif margin style font time roman time serif margin nbsp style font time roman time serif margin confidential style font time roman time serif margin style font time roman time serif margin nbsp certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text align center margin bottom nbsp nbsp style font normal time roman time serif margin text align center text indent master license agreement style font normal time roman time serif margin text align justify text indent nbsp style font normal time roman time serif margin text align justify text indent this master license agreement made entered into effective july ldquo effective date rdquo between purdue research foundation statutory body corporate formed existing under indiana foundation holding company hereinafter referred ldquo rdquo endocyte affiliate kent suite west lafayette delaware corporation collectively hereinafter referred ldquo endocyte rdquo collectively referred hereinafter ldquo party rdquo style font normal time roman time serif margin text align center text indent nbsp style font normal time roman time serif margin text align center text indent witnesseth style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent whereas endocyte sponsored continues sponsor research conducted purdue university pursuant term master research agreement between endocyte purdue university restated march amended july further amended from time time hereafter ldquo rdquo style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent whereas designates administer matter pertaining protection commercialization intellectual property developed thereunder style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent whereas endocyte desire hereby enter into this agreement whereby endocyte obtains license commercialize each eligible disclosure that elect license style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent whereas willing enter into this agreement with endocyte under term condition forth herein style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent therefore consideration mutual covenant premise contained herein receipt sufficiency which hereby acknowledged party hereto agree follows style font normal time roman time serif margin text align center nbsp style font normal time roman time serif margin text align center section definition style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent following term used herein shall have following meaning style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo affiliate rdquo mean entity which control controlled under common control with another erson purpose this definition only ldquo control rdquo mean posse directly indirectly through more intermediary power direct management policy entity whether through ownership voting security contract relating voting right corporate governance directly indirectly more than fifty percent outstanding voting security other ownership interest such entity style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo agreement rdquo ldquo license agreement rdquo ldquo master license agreement rdquo mean this agreement including schedule attached this agreement style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo annual period rdquo mean calendar year during term agreement style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo commercially reasonable effort rdquo mean with respect commercialization licensed technology effort that consistent with those utilized company size type similar endocyte applicable sublicensee product with similar commercial potential similar stage taking into consideration their cost develop competitiveness alternative product nature extent their market exclusivity likelihood regulatory approval their profitability other relevant factor style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin confidential style font normal time roman time serif margin certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence option newsection value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent nbsp nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo eligible disclosure rdquo mean technology disclosure forth inarticle that disclosed writing prof philip whether alone conjunction with purdue personnel defined herein derived from project that term defined within endocyte field defined funded solely endocyte combination endocyte fund gift fund internal purdue fund rendered ineligible election license pursuant section internal revenue code regulation promulgated thereunder anticipated that subject matter eligible disclosure will include limited subject matter forth exhibit which endocyte amend from time time style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo elected eligible disclosure rdquo mean eligible disclosure that endocyte timely elect license pursuant procedure term forth date upon which such timely election occurs referred ldquo election date rdquo shall date upon which elected eligible disclosure scheduled licensed endocyte pursuant this master license agreement style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo endocyte contribution rdquo mean with respect eligible disclosure material purdue personnel supplied endocyte purdue university pursuant material transfer documentation between endocyte purdue university style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo federal policy rdquo mean regulation applicable intellectual property funded whole part government including without limitation sect sect part style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo field rdquo mean including limited commercialization directed endocyte field defined style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo gross receipt rdquo mean amount received endocyte subsidiary distributor sublicensee consideration part sale licensed technology that covered valid claim jurisdiction where consideration tendered following extent actually taken occurring product return excise sale tariff specific licensed technology that covered valid claim customer reimbursement enumerated third party delivery charge adjustment deduction from gross receipt shall made permitted sale commission internal sale corporate affiliate collection cost style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent ldquo indemnitees rdquo mean purdue university their respective officer director employee legal representative style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent ldquo licensed patent rdquo mean extent arising from elected eligible disclosure patent application issued patent referenced schedule amended from time time party patent patent application related clause filed accordance with section whether referenced schedule which claim priority excluding where such priority claim denied disallowed under sect benefit filing date under sect sect divisionals continuation continuation part reissue renewal substitution registration examination revalidations extension supplementary protection certificate provided that foregoing filed with rsquo prior approval with assignee patent issuing from patent patent application described clause reissue renewal reexamination extension patent patent application described clause foreign counterpart equivalent patent patent application described clause style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent confidential style font normal time roman time serif margin text indent certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent style font normal time roman time serif margin text indent ldquo licensed technology rdquo mean good service including process machine manufacture composition matter that part employ embodies developed reliance upon information from elected eligible disclosure licensed patent whose development manufacture sale offer sale importation exportation would license granted herein infringe least valid claim style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent ldquo licensed territory rdquo mean worldwide style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo other receipt rdquo mean amount received endocyte subsidiary distributor sublicensee consideration part provision technology that licensed technology covered valid claim where consideration tendered where valid claim covering licensed technology exist united state canada japan china germany france united kingdom italy spain following extent actually taken occurring product return excise sale tariff specific licensed technology covered valid claim customer reimbursement enumerated third party delivery charge adjustment deduction from other receipt shall made permitted sale commission internal sale corporate affiliate collection cost style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo payment date rdquo mean date which royalty payment shall payable within thirty each reporting period april july october january style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo purdue personnel rdquo mean following individual they purdue resource subject purdue intellectual property policy including prior future iteration such policy prof philip purdue fellow student technician scientist other personnel employed otherwise affiliated with purdue working under supervision direction prof philip style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo registration trial rdquo mean pivotal safety efficacy study used appropriate governmental entity determine whether approve investigational drug example food drug administration forth sect style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent ldquo reporting period rdquo mean quarterly period ending april july october january annual period style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo sublicense rdquo mean sublicensing agreement arrangement between endocyte third party which third party granted license other permission part licensed patent holder sublicense ldquo sublicensee rdquo style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo target rdquo mean cell surface receptor including limited cell surface receptor forth exhibit style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo third party clearance license rdquo mean with respect particular licensed technology license purchased endocyte from affiliated third party order mitigate demonstrable risk that third party otherwise exclude endocyte from practicing under valid claim that cover such licensed technology style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo valid claim rdquo mean pending issued claim that contained patent application filed accordance with section this agreement naming assignee issued unexpired patent based patent application filed accordance with section this agreement been revoked held unenforceable invalid decision court other governmental agency competent jurisdiction which decision appealable been appealed within time allowed appeal been disclaimed denied admitted invalid unenforceable through reissue examination disclaimer otherwise style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent confidential style font normal time roman time serif margin text indent certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent style font normal time roman time serif margin text align center section grant license style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp license subject compliance with this agreement subject reservation right stated below grant endocyte field licensed territory style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp exclusive license under licensed patent develop commercialize make have made sell offer sale import export licensed technology royalty bearing basis style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp exclusive license under data corresponding licensed patent only extent such assigned arose directly performance work professor philip purdue personnel under style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent right issue sublicenses term condition consistent with this agreement endocyte shall remain fully liable under this agreement omission respective sublicensees style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp implied license license right granted this agreement shall construed confer license right upon endocyte implication estoppel otherwise technology including data patent patent application trademark trademark application copyright trade secret other proprietary right specifically expressly encompassed term this agreement right expressly granted endocyte under this agreement expressly reserved style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp reservation right retains behalf itself purdue university research collaborator following right style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp practice under licensed patent make licensed technology royalty free basis solely commercial research scholarly teaching education patient care incidental foregoing other similar commercial including without limitation sponsored research collaboration ldquo commercial rdquo style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp license government agency university other educational institution organization type described sect internal revenue code scientific educational organization qualified under state nonprofit organization statute foreign equivalent foregoing ldquo commercial organization rdquo practice under licensed patent make licensed technology royalty free basis commercial style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp disseminate publish scientific finding from research related licensed patent licensed technology permit respective personnel including purdue university personnel same style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp government right licensed patent portion thereof have been developed with financial other assistance provided united state government applicable endocyte acknowledges agrees that accordance with public other statute regulation executive order exist amended enacted including without limitation federal policy united state government certain right invention licensed patent endocyte shall take action necessary enable behalf purdue university satisfy obligation under federal shall take action cause taking such action contrary fulfillment these obligation shall cooperate with endocyte such action either party aware financial other assistance provided united state government related licensed patent they shall promptly notify other party style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent confidential style font normal time roman time serif margin text indent certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent style font normal time roman time serif margin text align center section diligence commercialization style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp validation eligible disclosure evaluation each elected eligible disclosure endocyte will commence election date earlier endocyte providing written notice favorable review month from date receipt such longer period party mutually agree ldquo validation date rdquo shall under obligation agree date that greater than month from election date validation date elected eligible disclosure shall become ldquo validated disclosure rdquo style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp commercialization plan endocyte shall submit commercialization plan each validated disclosure within thirty validation date which commercialization plan shall appended schedule along with corresponding diligence milestone diligence milestone date commercialization plan must developed using commercially reasonable effort endocyte endocyte shall cause sublicensee case frequently party deem appropriate than annually endocyte shall provide with update progress against commercialization plan each validated disclosure endocyte must promptly notify substantial change commercialization plan which would materially adversely affect deadline achieving milestone such change commercialization plan will require consent which shall unreasonably withheld style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensed technology market endocyte shall commercially reasonable effort bring validated disclosure market within reasonable time accordance with corresponding commercialization plan style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp diligence milestone each validated disclosure endocyte will commercially reasonable effort achieve following diligence milestone corresponding date shown ldquo diligence milestone date rdquo style font normal time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align colspan style border bottom black solid text align center vertical align bottom font style font size diligence milestone font style line height nbsp style border bottom black solid text align center vertical align bottom font style font size diligence milestone date font style vertical align style text align left vertical align bottom width font style font size font style width text align left vertical align bottom font style font size begin toxicology study compound developed based validated disclosure font style width line height text align left vertical align bottom nbsp style text align left vertical align bottom width font style font size anniversary relevant validation date font style vertical align style text align left vertical align bottom font style font size font style text align left vertical align bottom font style font size initiation registration trial territory compound developed based avalidated disclosure font style line height text align left vertical align bottom nbsp style text align left vertical align bottom font style font size anniversary relevant validation date font style vertical align style text align left vertical align bottom font style font size font style text align left vertical align bottom font style font size first commercial sale territory compound developed based validated disclosure font style line height text align left vertical align bottom nbsp style text align left vertical align bottom font style font size anniversary completion registration trial font table style font normal time roman time serif margin text align justify text indent nbsp style font normal time roman time serif margin text align justify text indent additionally development technology validated disclosure endocyte will year assign minimum level staffing expenditure direct research product development cost accordance with schedule below style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent confidential style font normal time roman time serif margin text indent certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent style font normal time roman time serif margin text align justify text indent nbsp table cellpadding cellspacing width style font normal time roman time serif margin margin bottom style vertical align style width style width style text align justify prior achievement diligence milestone table table cellpadding cellspacing width style font normal time roman time serif margin margin bottom style vertical align style width style width font style font family time roman time serif font style text align justify full time employee table style font normal time roman time serif margin text align justify text indent nbsp table cellpadding cellspacing width style font normal time roman time serif margin margin bottom style vertical align style width style width style text align justify following achievement diligence milestone prior commencement phase clinical study territory table table cellpadding cellspacing width style font normal time roman time serif margin margin bottom style vertical align style width style width font style font family time roman time serif font style text align justify full time employee table table cellpadding cellspacing width style font normal time roman time serif margin margin bottom style vertical align style width style width font style font family time roman time serif font style text align justify table style font normal time roman time serif margin text align justify text indent nbsp table cellpadding cellspacing width style font normal time roman time serif margin margin bottom style vertical align style width style width style text align justify following commencement phase clinical study territory table table cellpadding cellspacing width style font normal time roman time serif margin margin bottom style vertical align style width style width font style font family time roman time serif font style text align justify full time employee table table cellpadding cellspacing width style font normal time roman time serif margin margin bottom style vertical align style width style width font style font family time roman time serif font style text align justify table style font normal time roman time serif margin text align justify text indent nbsp style font normal time roman time serif margin text align justify text indent following achievement diligence milestone prior achievement diligence milestone table cellpadding cellspacing width style font normal time roman time serif margin margin bottom style vertical align style width style width font style font family time roman time serif font style text align justify three full time employee table table cellpadding cellspacing width style font normal time roman time serif margin margin bottom style vertical align style width style width font style font family time roman time serif font style text align justify table style font normal time roman time serif margin text align justify text indent nbsp style font normal time roman time serif margin text indent avoidance doubt expenditure directed toward sponsored research laboratory professor philip purdue university shall considered expenditure direct research product development purpose these diligence milestone shall such expenditure directed towards direct research product development towards sponsored research laboratory professor philip purdue university creditable against these diligence milestone other payment under this agreement style font normal time roman time serif margin text align center nbsp style font normal time roman time serif margin text align center section consideration license style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp validation inclusion schedule each elected eligible disclosure shall amended schedule this agreement each elected eligible disclosure which first elected eligible disclosure directed particular target section shall apply section shall apply subsequent validated disclosure particular target style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp within validation date endocyte will following amount style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent validated disclosure that endocyte contribution style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent validated disclosure that endocyte contribution style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp elected eligible disclosure which endocyte under section first anniversary election date unless extension declare validation date granted under section shall excluded from schedule this agreement shall cease elected eligible disclosure shall cease licensed endocyte style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp each such subsequent validated disclosure section directed particular target endocyte agrees time refundable creditable each contributor such validated disclosure contributor previously licensed validated disclosure directed particular target follows style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent additional contributor validated disclosure that endocyte contribution style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent confidential style font normal time roman time serif margin text indent certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent style font normal time roman time serif margin text indent additional contributor validated disclosure that endocyte contribution style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent said shall within thirty scheduling validated disclosure onto schedule style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp each milestone applicable validated disclosure forth section endocyte shall achieve milestone required corresponding milestone date shown endocyte fails achieve milestone determined discretion that endocyte exercised commercially reasonable effort pursuit said milestone shall entitled discretion either terminate endocyte rsquo license validated disclosure remove validated disclosure from schedule this agreement require endocyte consideration waiver deadline date milestone issue style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp unit royalty each licensed technology covered valid claim endocyte shall earned royalty percentage gross receipt ldquo unit royalty rdquo endocyte sublicensees calculated licensed technology country country basis expiration latter last expire valid claim covering licensed technology that country year from first commercial sale licensed technology covered valid claim that country according following schedule style font normal time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align bottom width border bottom black solid text indent font style font size gross receipt font style vertical align width text indent line height nbsp style vertical align width border bottom black solid text indent font style font size licensed technology covered valid claim with endocyte contribution underlying eligible disclosure endocyte employee shown inventor corresponding licensed patent font style vertical align width text indent line height nbsp style text align left width border bottom black solid text indent vertical align middle font style font size licensed technology covered valid claim with endocyte contribution underlying eligible disclosure endocyte employee shown inventor corresponding nbsp nbsp licensed patent font style vertical align style text indent text align left vertical align bottom font style font size font style text indent line height text align center vertical align bottom nbsp style text indent text align center vertical align bottom font style font size font style text indent line height text align center vertical align bottom nbsp style text indent text align center vertical align bottom font style font size font style vertical align style text indent text align left vertical align bottom font style font size font style text indent line height text align center vertical align bottom nbsp style text indent text align center vertical align bottom font style font size font style text indent line height text align center vertical align bottom nbsp style text indent text align center vertical align bottom font style font size font table style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent unit royalty schedule other receipt shall calculated discount from schedule gross receipt ldquo discounted unit royalty rdquo licensed technology illustration royalty transaction that result gross receipt shall reduced royalty comparable transaction that result other receipt discounted unit royalty shall only licensed technology compound where valid claim cover that licensed technology compound least united state canada japan china germany france united kingdom italy spain quot other receipt jurisdiction quot absent valid claim covering licensed technology compound other receipt jurisdiction endocyte shall discounted unit royalty under this agreement style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent confidential style font normal time roman time serif margin text indent certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent style font normal time roman time serif margin text indent unit royalty discounted unit royalty shall payable before payment date each preceding reporting period style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp endocyte shall responsible compliance each sublicensee with term condition this agreement same manner same extent sublicensee were master licensee including without limitation payment unit royalty discounted unit royalty gross receipt style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp amount paid endocyte third party clearance license shall creditable unit royalty discounted unit royalty otherwise owed licensed technology that facilitated third party clearance license provided however that foregoing credit shall apply against minimum annual royalty payment under section shall apply offset more than unit royalty discounted unit royalty otherwise payable under section style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp maintenance endocyte shall refundable maintenance annum payable final reporting period first full annual period recurring annually through including final reporting period annual period which endocyte first unit royalty style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp minimum annual royalty each licensed technology which result gross receipt other receipt collectively ldquo total receipt rdquo endocyte shall guaranteed minimum annual royalty beginning with annual period ldquo year rdquo that follows first annual period ldquo year rdquo which total receipt occur minimum annual royalty owed year given licensed technology shall licensed technology each year year given licensed technology minimum annual royalty owed shall annum year each subsequent year given licensed technology minimum annual royalty shall annum amount from endocyte unit royalty discounted unit royalty each annual period shall creditable against minimum annual royalty that annual period event that unit royalty discounted unit royalty annual period exceed minimum annual royalty that annual period endocyte rsquo payment last reporting period each annual period shall include balance needed achieve minimum annual royalty that annual period minimum annual royalty paid creditable against unit royalty discounted unit royalty forth section style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp milestone payment each licensed technology which composition matter formulation thereof when endocyte sublicensee achieves milestone below endocyte will corresponding payment below which payment refundable creditable against royalty other payment style font normal time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width text indent text align left vertical align bottom font style font size milestone font style width text indent line height text align center vertical align bottom nbsp style width text align center vertical align bottom font style font size payment font style vertical align style text indent text align left vertical align bottom font style font size begin toxicology study composition matter formulation thereof font style text indent line height text align left vertical align bottom nbsp style text align center vertical align bottom font style font size font style vertical align style text indent text align left vertical align bottom font style font size commence registration trial territory composition matter formulation thereof font style text indent line height text align left vertical align bottom nbsp style text align center vertical align bottom font style font size font style vertical align style text indent text align left vertical align bottom font style font size first commercial sale territory composition matter formulation thereof font style text indent line height text align left vertical align bottom nbsp style text align center vertical align bottom font style font size font style vertical align style text indent text align left vertical align bottom font style font size total font style text indent line height text align left vertical align bottom nbsp style text align center vertical align bottom font style font size font table style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent confidential style font normal time roman time serif margin text indent certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp credit against unit royalty discounted unit royalty amount actually paid endocyte minimum annual royalty under section shall credited against unit royalty discounted unit royalty payable under section until aggregate such credit been exhausted provided that such amount only credited against unit royalty discounted unit royalty reduce amount paid reporting period maximum from amount otherwise unit royalty discounted unit royalty such that unit royalty discounted unit royalty actually paid reporting period shall than unit royalty discounted unit royalty reporting period style font normal time roman time serif margin text align center nbsp style font normal time roman time serif margin text align center section payment report style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp payment specified section endocyte shall make royalty payment before payment date address forth section originating outside united state payment shall made electronic fund transfer account identified endocyte shall absorb payment associated with such electronic fund transfer style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp currency conversion royalty paid endocyte hereunder shall paid dollar gross receipt shall converted dollar exchange rate existing between dollar relevant currency last applicable reporting period compliance with united state generally accepted accounting principle such rate reported wall street journal loss exchange value other expense incurred transfer conversion dollar shall paid entirely endocyte style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp interest interest shall accrue overdue payment required under this agreement rate month commencing thirtieth after payment date style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp royalty report each reporting period endocyte shall report information specified schedule royalty report requirement report required even earned royalty incomplete report deemed rsquo sole discretion material breach this agreement style font normal time roman time serif margin text align center nbsp style font normal time roman time serif margin text align center section record style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp record sale during term this agreement period five year thereafter endocyte shall keep true accurate record information relating gross receipt other receipt unit royalty discounted unit royalty sublicense income verification endocyte rsquo calculation amount payable under this agreement endocyte shall furnish that information upon rsquo request which shall made more often than once annual period style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent confidential style font normal time roman time serif margin text indent certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp audit record shall have right from time time reasonable time during normal business hour through independent certified public accountant examine record endocyte verify compliance with this agreement scope examination includes limited information necessary verify compliance with permitted scope practice under section sale invoice register sale analysis report original invoice inventory record price list sublicense distributor agreement accounting general ledger sale return such examination verification shall occur more than once each calendar year unless otherwise agreed writing endocyte expense performing such examination verification shall borne such examination reveals underpayment endocyte more than five percent quarter examined endocyte shall amount such underpayment plus interest accordance with section shall reimburse expense accountant performing examination style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text align center section patent prosecution style font normal time roman time serif margin text indent style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp prosecution counsel licensed patent ldquo prosecution counsel rdquo shall nominated endocyte approved shall jointly represent owner licensed patent endocyte exclusive licensee licensed patent endocyte shall each have right terminate prosecution counsel rsquo authority agent record licensed patent time style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp endocyte consultation with prosecution counsel shall have lead responsibility formulation implementation prosecution strategy subject prosecution counsel rsquo continuing obligation consultation with disclosure representation prosecution counsel shall extend proceeding patent office challenging validity licensed patent endocyte shall formulate implement patent coverage strategy commensurate scope with each elected eligible disclosure endocyte shall reasonable effort obtain patent coverage commensurate scope with disclosure each filed patent application based each elected eligible disclosure accordance with applicable patent style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp letter retention prosecution counsel shall address prosecution counsel rsquo responsibility following aspect style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp prosecution counsel shall make filing solely according joint instruction endocyte style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp prosecution counsel shall keep informed material development with respect filing prosecution maintenance patent application including advance notification prosecution proceeding strategy advance transmittal draft response patent office proceeding obtaining rsquo input prior filing same style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp except upon joint instruction endocyte prosecution counsel shall expressly irrevocably abandon either pending application within licensed patent except filing authorized continuing patent application fail make national filing style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp prosecution counsel shall advise inventorship consultation with endocyte prosecution counsel shall supply inventor assignment instrument endocyte shall each responsible obtaining executed assignment from their respective personnel style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp letter shall allocate responsibility maintenance style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent confidential style font normal time roman time serif margin text indent certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp endocyte shall solely responsible paying prosecution counsel rsquo billing prosecution each elected eligible disclosure licensed patent assigned prosecution counsel including limited maintenance applicable attorney rsquo expense official other charge incident preparation prosecution maintenance foreign patent application patent style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp party agree fully cooperate good faith with respect prosecution licensed patent style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp endocyte shall than ninety advance advise decision endocyte cease funding prosecution maintenance pending application except where there authorized continuing patent application patent which licensed patent that event upon payment said prosecution maintenance expense prosecution licensed patent shall thenceforth under sole control rsquo sole expense shall cease subject term condition this agreement shall subject abandonment lapse rsquo sole discretion this section shall apply endocyte mutually agree that commercial other reason licensed patent should longer prosecuted maintained style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp orange book listing patent term restoration endocyte sublicensees shall each have authority seek approval list eligible licensed patent orange book maintained shall provide opportunity comment will reasonably consider rsquo comment style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp other action extent licensed patent subject action specifically forth this section section party shall cooperate good faith determine appropriate course action accordance with this agreement style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text align center section abatement infringement style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notice infringement each party shall promptly inform other party suspected material infringement licensed patent style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp infringement action endocyte sublicensee shall have right obligation initiate suit take other appropriate action ldquo suit rdquo that endocyte sublicensee belief reasonably required protect licensed technology event that there suit agreement participate voluntarily plaintiff suit then extent necessary confer standing nbsp endocyte sublicensee hereby agrees object endocyte nbsp requesting court competent jurisdiction involuntarily join pursuant federal rule civil procedure plaintiff such suit nbsp connection with suit endocyte shall fully completely defend indemnify from against cost including attorney liability whether under counterclaim otherwise every kind incurred connection with suit nbsp extent that suit seek recovery damage infringement licensed patent party sublicensee participates suit shall agree negotiate good faith establish equitable formula sharing recovery suit nbsp event that said negotiation unsuccessful apportionment damage among plaintiff suit shall task finder fact suit style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent confidential style font normal time roman time serif margin text indent certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent style margin text align right nbsp style margin text align right style font normal time roman time serif margin text align center section confidentiality style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent endocyte shall without express prior written consent reason time either during subsequent term this agreement disclose third party other than counsel endocyte financial term forth this agreement except upon subpoena other court order required government security request consultant made with appropriate provision protection confidential information endocyte however show third party with reason know other term this agreement without notice style font normal time roman time serif margin text align center nbsp style font normal time roman time serif margin text align center section dispute resolution style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp negotiation dispute between party related this agreement arises either party written notice other party detailing point dispute ldquo dispute notice rdquo have dispute referred party rsquo respective officer designated below their successor attempted resolution good faith negotiation within thirty from date dispute notice designated officer follows style font normal time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style text indent text align left vertical align bottom width nbsp style width text indent text align left vertical align bottom font style font size endocyte font style text indent text align left vertical align bottom width font style font size with copy vice president business development chief intellectual property counsel font style vertical align style text indent text align left vertical align bottom nbsp style text indent text align left vertical align bottom nbsp style text indent text align left vertical align bottom nbsp style vertical align style text indent text align left vertical align bottom nbsp style text indent text align left vertical align bottom font style font size font style text indent text align left vertical align bottom font style font size president font table style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp mediation designated officer able resolve dispute within this thirty period agreed extension they shall confer good faith with respect possibility resolving matter through mandatory mediation with certified mediator indianapolis indiana under indiana rule alternative dispute resolution said mediation completed within sixty date dispute notice party shall participate mediation session good faith effort resolve dispute informal inexpensive manner expense mediator shall shared equally party style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp statute limitation admissibility evidence applicable statute limitation claim pending between party shall tolled during dispute resolution procedure under this agreement federal rule evidence indiana rule evidence indiana rule alternative dispute resolution shall apply their term evidence generated course operation this section style font normal time roman time serif margin text align center nbsp style font normal time roman time serif margin text align center section warranty merchantability exclusion warranty style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp limited warranty each party warrant other that fully empowered enter into this agreement style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent warranty endocyte endocyte represents warrant that style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp endocyte corporation duly organized validly existing good standing under state delaware endocyte requisite corporate power authority operate lease property carry business being conducted contemplated this agreement enter into this agreement carry transaction contemplated hereby specifically endocyte warrant that posse necessary expertise skill make made evaluation capability safety utility commercial application intellectual property licensed under this agreement style font time roman time serif margin margin bottom margin confidentialleft text indent text align justify nbsp style font time roman time serif margin margin bottom text indent text align justify confidential style font normal time roman time serif margin text indent certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin text indent nbsp nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp consent approval authorization designation declaration filing with governmental authority other person required part endocyte connection with execution delivery performance this agreement style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp endocyte endocyte rsquo knowledge none endocyte rsquo personnel party agreement instrument subject charter other corporate restriction judgment order writ injunction endocyte rsquo knowledge rule regulation which materially adversely affect operation prospect property asset condition financial otherwise endocyte style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp exclusion warranty warrant validity licensed patent licensed technology information provided support thereof warrant that foregoing free error defect make representation whatsoever with regard scope commercial potential profitability income from invention licensed patent licensed technology that invention licensed patent licensed technology exploited endocyte without infringing right other party make covenant either defend infringement charge third party institute action against infringers licensed patent warrant that product service within scope invention licensed patent licensed technology will meet endocyte rsquo endocyte rsquo customer rsquo specific requirement accordingly intellectual property licensed hereunder provided ldquo rdquo make representation warranty kind with respect intellectual property licensed hereunder expressly disclaims warranty merchantability fitness particular purpose other implied warranty with respect capability safety utility trade useage commercial application intellectual property licensed hereunder style font normal time roman time serif margin text align center nbsp style font normal time roman time serif margin text align center section damage indemnification insurance style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp limitation liability party breach this agreement shall liable other party incidental indirect exemplary consequential damage breach this agreement including without limitation lost profit business revenue goodwill regardless whether party aware possibility such damage further shall liable endocyte sublicensee special incidental indirect consequential damage resulting from defect design testing labeling manufacture distribution sale other application licensed technology style font normal time roman time serif margin text indent nbsp style font normal time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp indemnification except gross negligence willful misconduct indemnitees endocyte shall defend indemnify hold indemnitees harmless from third party claim demand action cause action arising connection with injury loss damage liability kind whatsoever arising directly indirectly practice under licensed patent pursuant this agreement exploitation distribution sale licensed technology this indemnification obligation shall include without limiting generality foregoing reasonable attorney other cost expense incurred indemnitees connection with defense such claim demand action cause action style font time roman time serif margin margin bottom margin left confidential text indent text align justify nbsp style font time roman time serif margin margin bottom text indent text align justify confidential style font normal time roman time serif margin text indent nbsp certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font normal time roman time serif margin text indent style font normal time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font normal time roman time serif margin style font normal time roman time serif margin text indent nbsp style margin style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp insurance requested conjunction with each royalty report made under section annual period endocyte shall supply with certificate insurance confirming coverage follows comprehensive general liability including endorsement product liability claim arising from licensed technology endocyte shall also maintain clinical trial insurance self insure amount considered reasonable industry style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notice claim shall promptly notify endocyte claim involving indemnitees will provide information requested endocyte evaluation each such claim style font time roman time serif margin text indent nbsp style font time roman time serif margin text align center section term termination style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp term unless terminated earlier accordance with this agreement this agreement expires expiration date last expire valid claim ldquo term rdquo style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent failure dispute regarding payment demanded from endocyte under this agreement shall administered under provision forth section nbsp event failure endocyte payable under this agreement failure endocyte cure nonpayment default sixtieth after endocyte rsquo receipt dispute notice from under section terminate this agreement license granted hereunder effective date rsquo issuance written notice confirming endocyte rsquo failure cure style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nonpayment default material breach event material default material breach this agreement endocyte other than nonpayment loss financial capability terminate this agreement license granted hereunder after serving endocyte with written notice material default material breach endocyte fails cure material default material breach within ninety receipt rsquo written notice thereof termination becomes automatically effective conclusion ninety period provided however material default material breach cured exercise diligence within ninety then time cure extended rsquo sole discretion time reasonably necessary effect cure provided that endocyte promptly commences cure within said period time thereafter proceeds diligently cure material default material breach style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination endocyte endocyte terminate license under this agreement without cause upon written notice delivered three month prior date which endocyte intends termination effective event termination endocyte under this section endocyte agrees upon request expense provide with relevant existing data belonging solely custody possession control endocyte which endocyte used registering compound formulation comprising compound covered valid claim approval united state food drug administration foreign counterpart such jurisdiction where registration occurred shall have unrestricted right provide such data third party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp failure enforce failure either party time period time enforce provision this agreement shall construed waiver such provision waiver right such party thereafter enforce each every provision this agreement style font time roman time serif margin margin bottom maconfidentialrgin left text indent text align justify nbsp style font time roman time serif margin margin bottom text indent text align justify confidential style font time roman time serif margin text indent nbsp certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin text indent nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp assignment sublicenses endocyte shall take step reasonably necessary terminate each sublicense effective date termination endocyte rsquo license from under this agreement upon request endocyte sublicensee verification sublicensee that endocyte default obligation sublicensee rsquo sole discretion accept assignment sublicense including right consideration promised endocyte thereunder notwithstanding anything contained this agreement contrary shall bound following with respect sublicense duty obligation endocyte sublicensee which assumed performed because they inconsistent with applicable policy then effect duty obligation endocyte that exceed obligation licensor this agreement duty obligation endocyte contained sublicense that contained this agreement which extend beyond term style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp survival expiration termination this agreement shall relieve party obligation accruing prior such expiration termination such obligation unit royalty discounted unit royalty gross receipt other receipt obtained prior expiration termination provide associated royalty report under section provision section this agreement shall survive termination this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin confidential style font time roman time serif margin certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font time roman time serif margin text align center nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin text align center style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center section notice style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent except otherwise provided herein notice other communication shall hand delivered sent private overnight mail service sent registered certified mail postage prepaid return receipt requested addressed party receive such notice other communication address given below such other address hereafter designated notice writing style font time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width text indent nbsp style width text indent font style font size font style width text indent font style font size purdue research foundation font style vertical align style text indent nbsp style text indent nbsp style text indent font style font size office technology commercialization font style vertical align style text indent nbsp style text indent nbsp style text indent font style font size hentschel blvd font style vertical align style text indent nbsp style text indent nbsp style text indent font style font size west lafayette font style vertical align style text indent nbsp style text indent nbsp style text indent font style font size facsimile font style vertical align style text indent nbsp style text indent nbsp style text indent font style font size attn assistant director font style vertical align style text indent nbsp style text indent nbsp style text indent nbsp style vertical align style text indent nbsp style text indent font style font size endocyte font style text indent font style font size endocyte font style vertical align style text indent nbsp style text indent nbsp style text indent font style font size chief executive officer font style vertical align style text indent nbsp style text indent nbsp style text indent font style font size kent suite font style vertical align style text indent nbsp style text indent nbsp style text indent font style font size west lafayette font table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent such notice other communication shall effective upon receipt employee agent representative receiving party authorized receive notice other communication sent delivered manner forth above style font time roman time serif margin text indent nbsp style font time roman time serif margin text align center section miscellaneous style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp export control endocyte acknowledges that subject united state regulation controlling export technical data computer software laboratory prototype other commodity that rsquo obligation under this agreement contingent upon compliance with applicable united state export regulation transfer technical data commodity require license from cognizant agency united state government written assurance endocyte that endocyte shall export data commodity certain foreign country without prior approval certain united state agency neither represents that export license shall required that required such export license shall issue style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp jurisdiction venue choice attorney rsquo justiciable dispute between endocyte shall determined solely exclusively under indiana court competent jurisdiction tippecanoe county indiana competent federal court indiana state court court competent jurisdiction prevailing party litigated dispute shall entitled reimbursement reasonable necessary attorney rsquo cost proof necessity those cost shall include evidence that prevailing party complied with procedure section this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp legal compliance endocyte shall comply with regulation relating manufacture processing production sale distribution licensed technology endocyte shall knowingly take action with respect licensed technology which would expose purdue university violation regulation style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp independent contractor endocyte rsquo relationship shall that licensee only endocyte agent shall have authority behalf matter person retained endocyte employee agent shall reason thereof deemed employee agent style font time roman time serif margin text indent nbsp style font time roman time serif margin margin bottom maconfidentialrgin left text indent text align justify confidential style font time roman time serif margin text indent nbsp certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin text indent nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp patent marking extent required applicable relevant jurisdiction endocyte shall mark licensed technology with applicable patent number otherwise give notice applicable patent number style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp name each party shall obtain written approval other party prior making their name commercial purpose except required exception foregoing endocyte each publicize existence this agreement publicize term condition this agreement without other party rsquo consent except required style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp place execution this agreement subsequent modification amendment hereto shall deemed have been executed state indiana style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp governing this agreement amendment modification alteration supplement hereto right party hereunder shall construed under governed state indiana without regard conflict rule united state america applicable style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp severability right restriction contained herein exercised shall applicable binding only extent that they violate applicable intended limited extent necessary that they will render this agreement illegal invalid unenforceable provision portion provision this agreement essential commercial purpose this agreement shall held illegal invalid unenforceable court competent jurisdiction intention party that remaining provision portion thereof shall constitute their agreement with respect subject matter hereof such remaining provision portion thereof shall remain full force effect extent legally permissible illegal invalid unenforceable provision this agreement shall replaced valid provision which will implement commercial purpose illegal invalid unenforceable provision event that provision essential commercial purpose this agreement held illegal invalid unenforceable replaced valid provision which will implement commercial purpose this agreement this agreement right granted herein shall terminate style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp force majeure delay failure performance party this agreement shall constitute default hereunder give rise claim damage extent caused occurrence beyond control party affected including limited strike other work stoppage civil disturbance fire flood explosion riot rebellion sabotage style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp assignment this agreement license granted hereunder assigned either party except upon prior written consent other party such consent unreasonable withheld provided however endocyte need obtain rsquo consent assignment this agreement conjunction with merger acquisition sale substantially asset endocyte style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp previous license endocyte party previously executed license agreement license agreement december effective december superceded exclusive license entered july also effective december restated october subsequently amended exclusive license agreement march subsequently amended collectively quot preexisting license agreement quot nothing this agreement shall amend alter otherwise affect term portion preexisting license agreement style font time roman time serif margin margin bottom margin left text indent text align justify nbsp style font time roman time serif margin margin bottom margin left text indent text align justify confidential style font time roman time serif margin text indent nbsp certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin text indent nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp modification this agreement shall modified amended terminated except herein provided except another agreement writing executed party hereto style font time roman time serif margin text indent nbsp style font time roman time serif margin margin bottom margin left text indent inconfidential text align justify confidential style font time roman time serif margin margin bottom margin left text align justify certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin text indent nbsp nbsp style font time roman time serif margin text indent witness whereof endocyte have caused this agreement signed their duly authorized representative under seal year indicated above style font time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width text indent font style font size purdue research foundation font style width text indent nbsp style width text indent font style font size endocyte affiliate font style vertical align style text indent nbsp style text indent nbsp style text indent nbsp style vertical align style border bottom black solid text indent font style font size daniel hasler font style text indent nbsp style border bottom black solid text indent font style font size elli font style vertical align style text indent font style font size daniel hasler font style text indent nbsp style text indent font style font size elli font style vertical align style text indent font style font size president chief entrepreneurial officer font style text indent nbsp style text indent font style font size president font table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent confidential style font time roman time serif margin text indent nbsp certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin text indent nbsp nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left confidential style font time roman time serif margin text align left nbsp certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font time roman time serif margin text align left nbsp field page sequence option newsection value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align left width style text align center width page field sequence type upperletter name pageno field sequence style text align right width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin text align left nbsp nbsp style font time roman time serif margin text align left schedule elected eligible disclosure licensed patent style font time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width text indent font style font size title elected eligible disclosure font style width text indent nbsp style width text indent nbsp style vertical align style text indent nbsp style text indent nbsp style text indent nbsp style vertical align style text indent font style font size reference number elected eligible disclosure font style text indent nbsp style text indent nbsp style vertical align style text indent nbsp style text indent nbsp style text indent nbsp style vertical align style text indent font style font size contributor elected eligible disclosure font style text indent nbsp style text indent nbsp table style font time roman time serif margin text align left nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse nowrap style vertical align bottom width text indent border bottom black solid font style font size font font style font size reference font font style font size number font nowrap style vertical align width text indent padding bottom nbsp nowrap style vertical align bottom width text indent border bottom black solid font style font size title nbsp font font style font size application font nowrap style vertical align width text indent padding bottom nbsp nowrap style vertical align bottom width text indent border bottom black solid font style font size serial font font style font size number font nowrap style vertical align width text indent padding bottom nbsp nowrap style vertical align bottom width text indent border bottom black solid font style font size inventor font nowrap style vertical align width text indent padding bottom nbsp nowrap style vertical align bottom border bottom black solid text indent width font style font size filing nbsp date font nowrap style vertical align width text indent padding bottom nbsp nowrap style vertical align bottom width text indent border bottom black solid font style font size jurisdiction font nowrap style vertical align width text indent padding bottom nbsp nowrap style vertical align bottom width text indent border bottom black solid font style font size status font style vertical align style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style vertical align style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp style text indent nbsp table style font time roman time serif margin text align left nbsp nbsp style font time roman time serif margin text align left confidential style font time roman time serif margin text align left nbsp certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended style font time roman time serif margin text align left nbsp field page sequence option newsection value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align left width style text align center width page field sequence type upperletter name pageno field sequence style text align right width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin text indent nbsp nbsp style font time roman time serif margin text align center schedule commercialization plan style font time roman time serif margin text align center text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width text indent border bottom black solid font style font size diligence milestone font style width text indent padding bottom nbsp style width text indent border bottom black solid font style font size diligence milestone date font style padding left text indent font style font size nbsp nbsp nbsp nbsp begin toxicology study compound developed based validated disclosure font style vertical align text indent nbsp style text indent nbsp style padding left text indent nbsp style vertical align text indent nbsp style text indent nbsp style padding left text indent font style font size nbsp nbsp nbsp nbsp initiation registration trial territory compound developed based validated disclosure font style vertical align text indent nbsp style text indent nbsp style padding left text indent nbsp style vertical align text indent nbsp style text indent nbsp style padding left text indent font style font size nbsp nbsp nbsp nbsp first commercial sale territory compound developed based validated disclosure font style vertical align text indent nbsp style text indent nbsp table style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left confidential style font time roman time serif margin text align left nbsp certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align left width style text align center width nbsp style text align right width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin text indent nbsp nbsp style font time roman time serif margin text align center schedule royalty report requirement style font time roman time serif margin text indent nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align text align justify style width style width text align left style text align justify identify each licensed technology name number brand identification sold endocyte during reporting period table table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align text align justify style width style width text align left nbsp style text align justify nbsp table table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align text align justify style width style width text align left style text align justify each identified licensed technology number unit sold endocyte each sublicensee during reporting period table table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align text align justify style width style width text align left nbsp style text align justify nbsp table table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align text align justify style width style width text align left style text align justify each identified licensed technology gross receipt during reporting period include summary netting calculation break sublicensee section table table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align text align justify style width style width text align left nbsp style text align justify nbsp table table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align text align justify style width style width text align left style text align justify each identified licensed technology amount unit royalty discounted unit royalty applicable minimum annual royalty including credit minimum annual royalty against unit royalty discounted unit royalty reporting period show monetary conversion rate applicable table table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align text align justify style width style width text align left nbsp style text align justify nbsp table table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align text align justify style width style width text align left style text align justify current certificate insurance section table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text align left confidential style font time roman time serif margin text align left nbsp certain confidential information contained this document marked with bracket been omitted filed separately with security exchange commission pursuant request confidential treatment pursuant applicable rule security exchange amended rule nbsp security amended field page sequence option last style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align left width style text align center width nbsp style text align right width nbsp table field page style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp body html text document